GluR1 phosphorylation and persistent expression of levodopa-induced motor response alterations in the hemi-parkinsonian rat

Neurochemical Research

Volumn 36, Issue 6, 2011, Pages 1135-1144

  Ba, Maowen ^a   Kong, Min ^b   Yu, Guoping ^a   Sun, Xuwen ^a   Liu, Zhuli ^a   Wang, Xiaotong ^a  

^a YANTAI YUHUANGDING HOSPITAL   (China)

^b YANTAISHAN HOSPITAL   (China)

Author keywords

GluR1; Motor response alterations; Parkinson's disease; Phosphorylation; Protein kinase A

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BENSERAZIDE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; GLUTAMATE RECEPTOR 1; LEVODOPA; OXIDOPAMINE; PARVALBUMIN; SERINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATIONAL STUDY; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; DRUG RESPONSE; DYSKINESIA; ENZYME INHIBITION; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOTOR PERFORMANCE; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; SINGLE DRUG DOSE;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; IMMUNOHISTOCHEMISTRY; LEVODOPA; MOTOR ACTIVITY; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA;

ANIMALIA; PARKINSONIA; RATTUS;

EID: 79955687283     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-011-0461-y     Document Type: Article

References (38)

1. Chen JJ, Swope DM (2007) Pharmacotherapy for Parkinson's disease. Pharmacotherapy 27:161S-173S
2. Standaert DG, Stern MB (1993) Update on the management of Parkinson's disease. Med Clin North Am 77:169-183 (Pubitemid 23066803)
3. Stacy M, Galbreath A (2008) Optimizing long-term therapy for Parkinson disease: levodopa, dopamine agonists, and treatment-associated dyskinesia. Clin Neuropharmacol 31:51-56 (Pubitemid 351321441)
4. Chase TN, Oh JD (2000) Striatal mechanisms and pathogenesis of Parkinsonian signs and motor complications. Ann Neurol 47:S122-S129
5. Chase TN, Oh JD (2000) Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism. Trends Neurosci 23:S86-S91
6. Obeso JA, Rodriguez-Oroz MC, Chana P et al (2000) The evolution and origin of motor complications in Parkinson's disease. Neurology 55:S13-S20
7. Papa SM, Engber TM, Kask AM et al (1994) Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration. Brain Res 662:69-74 (Pubitemid 24326863)
8. Lundblad M, Andersson M, Winkler C et al (2002) Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease. Eur J Neurosci 15:120-132 (Pubitemid 35478015)
9. Marin C, Aguilar E, Bonastre M et al (2005) Early administration of entacapone prevents levodopa-induced motor fluctuations in hemiparkinsonian rats. Exp Neurol 192:184-193 (Pubitemid 40208552)
10. Mouradian MM, Heuser IJ, Baronti F et al (1990) Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease. Ann Neurol 27:18-23 (Pubitemid 20031354)
11. Calon F, Grondin R, Morissette M et al (2000) Molecular basis of levodopa-induced dyskinesias. Ann Neurol 47:70-78
12. Jenner P (2000) Pathophysiology and biochemistry of dyskinesia: clues for the development of non-dopaminergic treatments. J Neurol 247:43-50
13. Graybiel AM, Canales JJ, Capper-Loup C (2000) Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis. Trends Neurosci 23:71-77
14. Greenamyre JT (2000) New targets for therapy in Parkinson's disease: pathogenesis and pathophysiology. Neurol 15:67-80
15. Nakanishi S, Nakajima Y, Masu M et al (1998) Glutamate receptors: brain function and signal transduction. Brain Res Brain Res Rev 26:230-235 (Pubitemid 28318078)
16. Malinow R, Malenka RC (2002) AMPA receptor trafficking and synaptic plasticity. Annu Rev Neurosci 25:103-126 (Pubitemid 34748013)
17. Oh JD, Chase TN (2002) Glutamate-mediated striatal dysregulation and the pathogenesis of motor response complications in Parkinson's disease. Amino Acids 23:133-139
18. Lee HK, Takamiya K, Han JS et al (2003) Phosphorylation of the AMPA receptor GluR1 subunit is required for synaptic plasticity and retention of spatial memory. Cell 112:631-643 (Pubitemid 36331776)
19. Roche KW, Obrien RJ, Mammen AL et al (1996) Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit. Neuron 6:1179-1188 (Pubitemid 26227239)
20. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edn. Academic Press, London
21. Kong M, Ba MW, Song L et al (2009) Comparative effects of acute or chronic administration of levodopa to 6-OHDA-lesioned rats on the expression and phosphorylation of N-methyl-Daspartate Receptor NR1 subunits in the striatum. Neurochem Res 34:1513-1521
22. Oh JD, Del Dotto P, Chase TN (1997) Protein kinase A inhibitor attenuates levodopa-induced motor response alterations in the hemi-parkinsonian rat. Neurosci Lett 228:5-8 (Pubitemid 27288523)
23. Dunah AW, Standaert DG (2001) Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane. J Neurosci 21:5546-5558 (Pubitemid 32692153)
24. Starr MS (1995) Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease. Synapse 19:264-293
25. Lange KW, Kornhuber J, Riederer P (1997) Dopamine/glutamate interactions in Parkinson's disease. Neurosci Biobehav Rev 21:393-400 (Pubitemid 27255844)
26. Konitsiotis S, Blanchet PJ, Verhagen L et al (2000) AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys. Neurology 54:1589-1595 (Pubitemid 30226801)
27. Marin C, Jimenez A, Bonastre M et al (2000) Non-NMDA receptor-mediated mechanisms are involved in levodopa-induced motor response alterations in parkinsonian rats. Synapse 36:267-274 (Pubitemid 30257311)
28. Perier C, Marin C, Bonastre M et al (2002) AMPA receptor antagonist LY293558 reverses preproenkephalin mRNA overexpression in the striatum of 6-OHDA-lesioned-rats treated with L-dopa. Eur J Neurosci 16:2236-2240 (Pubitemid 35454268)
29. Wang JQ, Arora A, Yang L et al (2005) Phosphorylation of AMPA receptors: mechanisms and synaptic plasticity. Mol Neurobiol 32:237-249 (Pubitemid 41749422)
30. Boehm J, Malinow R (2005) AMPA receptor phosphorylation during synaptic plasticity. Biochem Soc Trans 33:1354-1356 (Pubitemid 41779686)
31. Rivera A, Alberti I, Martin AB et al (2002) Molecular phenotype of rat striatal neurons expressing the dopamine D5 receptor subtype. Eur J Neurosci 16:2049-2058 (Pubitemid 35454249)
32. Bolam JP, Hanley JJ, Booth PAC et al (2000) Synaptic organisation of the basal ganglia. J Anat 196:527-542 (Pubitemid 30458775)
33. Oh JD, Russell D, Vaughan CL et al (1998) Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: Effect of dopaminergic denervation and levodopa administration. Brain Res 813:150-159 (Pubitemid 29012528)
34. Oh JD, Vaughan CL, Chase TN (1999) Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits. Brain Res 813:433-442 (Pubitemid 29222808)
35. Kotter R (1994) Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum. Prog Neurobiol 44:163-196
36. Miserendino MJ, Nestler EJ (1995) Behavioral sensitization to cocaine: modulation by the cyclic AMP system in the nucleus accumbens. Brain Res 672:299-306
37. Lee HK, Barbarosie M, Kameyama K et al (2000) Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity. Nature 405:955-959 (Pubitemid 30435052)
38. Slipczuk L, Bekinschtein P, Katche C et al (2009) BDNF activates mTOR to regulate GluR1 expression required for memory formation. PLoS One 4:e6007